Variable Value Value Value P value
All (n=86) Group A (n=25) Group B (n=61)
Male sex 50 (58) 17 (68) 33 (54) 0.34
Age [years], median(IQR) 64 (54-69) 67 (60-71) 62 (53-68) 0.046
NYHA class NYHA I
NYHA II
NYHA III
NYHA IV
27 (31) 46 (54) 10 (12) 3 (3.5) 7 (28) 13 (52) 2 (8.0) 3 (12) 20 (33) 33 (54) 8 (13) 0
0.049
Previous cardiac surgery 15 (17) 3 (12) 12 (20) 0.54
Chronic aortic dissection 30 (35) 11 (44) 19 (31) 0.32
Aortic root aneurysm 13 (15) 2 (8.0) 11 (18) 0.33
Ascending aorta aneurysm 70 (81) 21 (84) 49 (80) 0.77
Descending aorta aneurysm 33 (38) 6 (24) 27 (44) 0.09
Saccular aortic arch aneurysm 3 (3.5) 2 (8.0) 1 (1.6) 0.20
Arterial hypertension 65 (78) 20 (90.9) 45 (74) 0.13
Coronary artery disease 18 (21) 6 (24) 12 (20) 0.77
Mitral valve regurgitation No Trace Mild Moderate Severe (n=68) 12 (18) 26 (38) 19 (28) 7 (10) 4 (5.9) (n=7) 0 5 (71) 1 (14) 0 1 (14) (n=61) 12 (20) 21 (34) 18 (30) 7 (12) 3 (4.9)
0.21
Tricuspid valve regurgitation No Trace Mild Moderate Severe (n=68) 22 (32) 19 (28) 19 (28) 6 (8.8) 2 (2.9) (n=7) 2 (29) 3 (43) 1 (14) 1 (14) 0 (n=61) 20 (33) 16 (26) 18 (30) 5 (8.2) 2 (3.3)
0.80
Renal function Normal (GFR>85ml/min/1.73m2) Moderately impaired [GFR 50-85ml/min/1.73m2] Severely impaired [GFR<35ml/min/1.73m2] Dialysis 50 (58) 28 (33) 7 (8.1) 1 (1.2) 12 (48) 8 (32) 4 (16) 1 (4.0) 38 (62) 20 (33) 3 (4.9) 0
0.13
Diabetes (n=83)
9 (11)
4 (18) (n=22) 5 (8.2) (n=61)
0.24
BMI [kg/m2], median(IQR) 27 (24-30) 28 (25-30) 26 (24-30) 0.25
Serum creatinine [mg/dl], median(IQR) 0.87 (0.74-1.08) 1.02 (0.79-1.37) 0.82 (0.70-1.00) 0.004
EF [%], median (IQR), (n=85) 55 (50-60) 50 (45-60) 55 (50-60) 0.06
EUROSCORE II, median (IQR) 4.98 (3.01-8.89) 4.29 (2.82-8.39) 5.34 (3.23-9.15) 0.42